NSEGeneral Updates5d ago · 10 Oct 2026, 06:25 pm

General Updates

Solara Active Pharma Sciences Limited · SOLARA

✦ AI SummaryESG

Solara Active Pharma Sciences Limited has received an ESG rating of Crisil ESG 63 under the Strong category from Crisil ESG Ratings & Analytics Limited for Fiscal 2026.

Analysis Scores

Earnings Impact1/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Solara Active Pharma Sciences Limited has informed the exchange regarding the ESG rating received from Crisil ESG Ratings & Analytics Limited.

Attachments (1)

📄

SOLARA_10102026182311_SE_Intimation_ESG_Rating.pdf

pdf

Download →
View document text
Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in Date: October 10, 2026 The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra-Kurla Dalal Street, Mumbai – 400 001 Complex, Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1 Dear Sir / Madam, Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Intimation of ESG Rating. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, we wish to inform you that the Company has received ESG Rating for Fiscal 2026 (period ended March 31, 2026) from Crisil ESG Ratings & Analytics Limited (‘Crisil ESG Ratings’), a SEBI registered Category 1 ESG rating provider, vide its email dated October 09, 2026. The details of the rating are as under: Type of Rating Environmental, Social and Governance (ESG) rating Rating received Crisil ESG 63 under Strong category (upgraded from Crisil ESG 56 for the period ended March 31, 2025) Please note that the Company has not engaged CRISIL ESG Ratings for the ESG rating. The aforesaid rating has been assigned independently by CRISIL ESG Ratings based on the disclosures made by the Company for the financial year 2026 and other publicly available information. This intimation is also being uploaded on the website of the Company at www.solara.co.in. We request you to take the above information on your records. Thanking You, Yours Faithfully, For Solara Active Pharma Sciences Limited Pooja Jaya Kumar Company Secretary and Compliance Officer Membership No: A57415 Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91-22-20870033